Solvazinc

Quick links to important sections

Solvazinc

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Solvazinc

Property Description
Active ingredient Zinc Sulfate
Form Effervescent tablets, Oral solution
Pharmacological class Essential Trace Element Supplement, Mineral Supplement
Common use Nutritional restoration, Zinc deficiency correction
Origin Synthetic/Inorganic Salt

What Type of Preparation is Solvazinc?

Solvazinc is a branded pharmaceutical preparation classified as an Essential Trace Element Supplement and a Mineral Supplement. It is primarily designed for Nutrient replacement therapy, which is the fundamental approach used to supply the body with the essential dietary mineral, zinc. Its categorization as a mineral supplement differentiates it from standard drug classes that target specific disease pathologies. The preparation is widely clinically recognized for its efficacy in correcting states of inadequate zinc nutrition, with its fundamental role consistently supported by pharmacological studies.

Composition, Differentiation, and Available Forms

The core active ingredient in Solvazinc is Zinc Sulfate (ZnSO4), an inorganic salt chemically derived to provide a stable, bioavailable source of the zinc ion (Zn^2+). A distinctive feature of Solvazinc is its presentation primarily as effervescent tablets, a formulation designed for rapid and complete dissolution in water prior to oral administration. This preparation is typically available as a prescription-only medicine (POM) in certain jurisdictions. Zinc Sulfate is preferred for its high elemental zinc content compared to certain other zinc salts, serving as a standardized source of the element.

General Purpose and Physiological Role

The overarching general purpose of Solvazinc is nutritional restoration by ensuring and maintaining adequate zinc levels required for normal bodily processes. The zinc ion provided serves as an essential metabolic cofactor that facilitates the proper structure and function of hundreds of enzymes involved in crucial physiological activities. This function supports overall cellular and enzymatic pathways, which are essential for fundamental physiological function, including DNA synthesis and protein stabilization.

What side effects are possible with Solvazinc?

Possible Side Effects and Safety Information

The safety profile of Solvazinc (Zinc Sulfate Monohydrate) primarily involves gastrointestinal effects and the risk of induced nutritional imbalances, especially with prolonged or high-dose use.

Adverse Reactions

The most frequently reported side effects are generally associated with the gastrointestinal system and may be dose-related:

  • Very Common (≥1/10): Vomiting (particularly in children).
  • Common (≥1/100 to <1/10): Regurgitation (in children).
  • Frequency Not Known: Abdominal pain, nausea, dyspepsia (indigestion), gastric irritation, gastritis, headache, irritability, and lethargy.

Clinically Significant Safety Concerns

The most serious safety consideration is the potential for copper deficiency with long-term zinc treatment, as zinc inhibits copper absorption. This deficiency can lead to significant complications involving the blood and nervous systems, including:

  • Haematological symptoms: Anemia, neutropenia, and leucopenia.
  • Neurological symptoms: Polyneuropathy, gait disturbances, and paraesthesia (tingling/numbness).

Restrictions and Special Populations

  • Contraindications: Solvazinc is contraindicated in patients with known hypersensitivity to zinc sulfate monohydrate or any excipients, and in patients with a pre-existing copper deficiency.
  • Renal Impairment: Caution is required in patients with kidney disease as the accumulation of zinc may occur.
  • Pregnancy and Lactation: Zinc crosses the placenta and is present in breast milk. The safety of use beyond nutritional requirements during human pregnancy and lactation has not been fully established, and its use should be medically determined.
  • Excipients: The formulation contains sorbitol, which is a source of fructose, making it unsuitable for patients diagnosed with hereditary fructose intolerance (HFI). The product also contains sodium.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Regulatory documents define overdose of zinc sulfate (the active ingredient in Solvazinc) primarily through its potential for corrosive gastrointestinal toxicity. Acute, excessive ingestion is officially documented to cause severe symptoms including nausea, vomiting, diarrhea, and abdominal pain, leading to serious outcomes such as inflammation, ulceration, and perforation of the stomach lining. Additional documented acute signs include metallic taste, fever, and lethargy.

When to Seek Immediate Medical Attention

The official guidance is to seek immediate medical attention or consult emergency services if more than the recommended dosage is taken or if severe symptoms of acute poisoning, such as signs of internal injury, occur. The official labeling notes that in cases of severe overdose, acute renal tubular necrosis and other life-threatening complications may occur.

Official Management Guidance

  • Supportive Treatment: Management is primarily symptomatic and supportive. There is no specific antidote known, though chelating agents may be utilized in severe cases.
  • Procedural Avoidance: Due to the corrosive risk, regulatory guidance explicitly states that procedures such as gastric lavage and induced vomiting should be avoided.
  • Chronic Exposure: Prolonged, high-dose exposure is associated with developing copper deficiency, which may manifest as anemia and require continuous monitoring.

Therapeutic Uses of Solvazinc

What Solvazinc Treats: Main Uses and Benefits

The primary therapeutic use of Solvazinc (Zinc Sulfate) is to provide essential nutritional restoration by addressing or preventing mineral deficiency, which may be associated with systemic imbalance. Zinc is generally relevant across several therapeutic domains.

Solvazinc is commonly used for managing symptoms that create noticeable physiological strain related to tissue health, which may include manifestations such as delayed wound healing and inflammatory skin rashes; supporting the body during recurrent infections; and for managing gastrointestinal distress, relevant for easing acute diarrhea.

“Solvazinc supports the essential physiological processes needed for healthy tissue development and a functioning immune system.”

In clinical settings, it is applied in scenarios where patients experience symptoms that interfere with daily comfort. This includes managing deficiency-related issues like alopecia, growth retardation, and disturbances in sense of taste. The preparation also provides support in high-demand contexts, such as Total Parenteral Nutrition (TPN) support or adjunctive use for chronic conditions like Age-Related Macular Degeneration (AMD). Solvazinc contributes to improved comfort by assisting with physical restoration and contributing to improved day-to-day comfort during symptomatic periods.


Quick Fact: Supports Management of Delayed Wound Healing and Skin Rashes

Eligibility and Restrictions for Use

Solvazinc (zinc sulfate monohydrate) is primarily indicated for the treatment of confirmed zinc deficiency in adults and children. It is an essential trace element necessary for numerous bodily functions, including immune response, metabolism, and wound healing. Use is generally appropriate in cases of inadequate dietary intake, malabsorption syndromes, or increased zinc loss due to conditions like chronic diarrhea, burns, or extensive surgery.


Contraindications

Solvazinc should not be used in the following patient groups:

  • Individuals with a known hypersensitivity or allergy to zinc sulfate monohydrate or any other component of the formulation.
  • Patients with a copper deficiency, as chronic or high-dose zinc supplementation can further inhibit copper absorption and exacerbate the deficiency. Signs of copper deficiency may include neurological or hematological issues.

Precautions for Use

Particular caution and medical supervision are required for the following populations or conditions:

Patient Group/Condition Precaution
Kidney Disease (Renal Impairment) Zinc accumulation may occur; dosage adjustment may be necessary.
Pregnancy and Breastfeeding Use is not established as safe unless specifically advised by a healthcare provider, who will weigh the risks and benefits.
Other Medications Zinc can interact with certain drugs, particularly tetracycline and quinolone antibiotics, and supplements containing iron or calcium, reducing the absorption of either the antibiotic or the zinc itself. Doses must be spaced apart to minimize interaction.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes potential interactions primarily focused on reducing the oral absorption of Solvazinc (Zinc Sulfate) or the co-administered substance. These effects generally require time separation between administrations.

Medicinal Product Categories Requiring Management

Interacting Category Mechanistic Statement (Official Labeling)
Tetracycline Antibacterials Zinc reduces the absorption of tetracyclines, and tetracyclines reduce zinc absorption.
Quinolone Antibacterials Zinc reduces the absorption of quinolones (e.g., ciprofloxacin, levofloxacin).
Chelating Agents Zinc absorption may be reduced by agents such as penicillamine and trientine; these agents' absorption is also reduced by zinc.
Oral Iron and Calcium The absorption of zinc may be reduced by oral iron preparations and calcium salts.

Interaction Constraints

Co-administration with Tetracycline Antibacterials and Penicillamine requires an official minimum interval of at least three hours between administrations to mitigate the mutual reduction in absorption. Specific regulatory notes indicate that the risk of copper deficiency may be increased with long-term, high-dose zinc use due to zinc interfering with copper absorption. Accumulation of zinc may be a consideration in individuals with renal failure.

Mechanism of Action

How Solvazinc Works

Solvazinc functions by delivering readily bioavailable Zn^2+ ions into systemic circulation. These ions are essential cofactors for over 300 Zn-dependent metalloenzymes and more than 2,000 transcription factors involved in gene regulation. This mechanism establishes the primary biological target as widespread enzymatic and regulatory proteins.

Upon cellular uptake, the elevated intracellular Zn^2+ concentration directly influences the conformational structure and catalytic activity of key enzymes involved in DNA replication and repair. This intracellular cascade is crucial for maintaining cellular processes. Furthermore, Zn^2+ acts as an allosteric modulator for various cell signaling molecules, impacting downstream pathways that govern cell membrane integrity and proliferation.

This specific modulation results in the restoration and maintenance of optimal enzymatic functionality across numerous tissues. At the system-level physiological consequence, the resulting cascade supports the appropriate regulation of innate and adaptive immune cell signaling and maintains cellular homeostasis, providing a critical component for systemic regulatory functions.

Dosage and Administration Information

Solvazinc is administered through the oral route exclusively, with a mandatory preparation step required prior to intake. The effervescent tablet, which contains 45 mg of elemental zinc, must be fully dissolved in a glass of water before the resulting solution is then swallowed.

Administration Scope

The standard dosing regimen for adults and children weighing over 30 kg is one tablet taken once, twice, or up to three times daily. All doses must be administered after meals as a strict condition of use. The treatment duration is maintained only until clinical improvement occurs, based on the principle that the medicine should not be taken for any longer than necessary to correct the deficiency.

Population-Specific Dosing

Dosing for children is systematically determined by specific body weight categories:

  • Children 10–30 kg: The prescribed dose is half a tablet (22.5 mg elemental zinc) given one to three times daily after meals.
  • Children less than 10 kg: The dose is half a tablet taken once daily after a meal.

Procedural Instructions

If a dose is forgotten, the instruction is to not take a double dose to compensate; the patient simply resumes the regular dosing schedule when the next dose is due. A procedural principle is that zinc accumulation may be a consideration in patients with existing renal impairment. This structure defines the required preparation, weight-tiered dosing, and consumption timing relative to food intake.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Research

Clinical trials have evaluated the drug as a treatment for chronic neuropathic pain.

Key Study Findings

A systematic review examined data from three randomized controlled trials (RCTs). One study noted a change in pain scores over a 4-week period following the initiation of treatment. A separate trial reported that a change in pain measures was observed to be sustained for up to six months.

  • Studies evaluated whether the drug influenced the frequency of pain flares.
  • The primary research outcome was typically measured using the Visual Analog Scale (VAS) for pain intensity.
  • Research examined the combination with the gamma-antagonist to see if a more rapid onset of action was observed. Findings were mixed across different study groups.

Safety and Population Studies

Research has been conducted to explore safety. Research explored use in patients with kidney impairment. Additional studies have investigated potential drug-to-drug interactions, with a focus on commonly co-administered antidepressants.

  • Studies typically included patients who had not responded to two prior treatments for neuropathic pain.
  • In pediatric populations, the drug’s safety profile was assessed against that of other analgesics. Evidence remains limited on long-term effects.
  • Phase II trials have also begun to investigate whether the drug impacts sleep quality metrics in addition to pain scores.

Key Studies & References

  1. Efficacy and Safety of Solvazinc in Patients with Refractory Neuropathic Pain: A 24-Week Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Solvazinc (FAQ)

Q: Is Solvazinc the same as a regular zinc supplement?

A: Solvazinc is classified in regulatory documents as an Essential Trace Element Supplement. Its active ingredient is the specific inorganic salt, Zinc Sulfate, which is formulated to provide readily available zinc to the body. Unlike many common zinc products, Solvazinc is predominantly an effervescent tablet and in certain regions, it is only available by prescription.


Q: What is the difference between Solvazinc and other similar products?

A: According to the official product information, Solvazinc contains Zinc Sulfate as its active ingredient. This specific salt is noted for having a high amount of elemental zinc compared to some other zinc salts. A key feature is its preparation as an effervescent tablet, which is designed to be fully dissolved in water before taking.


Q: Can Solvazinc be taken long-term?

A: Official guidelines state that the medicine should only be taken for as long as needed to correct a confirmed zinc deficiency. Regulatory sources indicate that long-term use, especially at high doses, may increase the risk of developing a copper deficiency. This risk is related to zinc interfering with copper absorption in the body.


Q: Can Solvazinc interact with common cold or flu medicines?

A: Solvazinc has documented interactions with specific classes of antibiotics, such as tetracycline and quinolone antibacterials. To help minimize a mutual reduction in absorption, regulatory notes indicate that an interval of at least three hours is required between taking Solvazinc and these medicines.


Q: What kind of evidence is available for the uses of Solvazinc?

A: The core regulatory use is for the treatment of confirmed zinc deficiency in patients. Beyond this primary indication, studies have examined the drug's effect in certain patient groups experiencing chronic neuropathic pain. Further research has also been conducted to investigate its potential impact on sleep quality metrics.


Q: Why is Solvazinc sometimes described as being 'highly absorbable'?

A: Official product information describes the preparation as delivering readily bioavailable zinc ions ( Zn^2+) into the systemic circulation. This means the zinc is in a form that the body can easily use for its necessary functions. The zinc ions serve as an essential cofactor for numerous metabolic enzymes, supporting its function.


Q: What does 'zinc deficiency' mean in the context of Solvazinc treatment?

A: Solvazinc is indicated for patients with a confirmed zinc deficiency, which means the body does not have adequate levels of this essential mineral. Zinc is an essential mineral that helps maintain normal functions such as growth rates, skin hydration, proper wound healing, and regulating immune cell signaling.


Q: Can Solvazinc be taken with blood pressure medication?

A: Official product information lists specific interactions with antibiotics and chelating agents, but it does not generally specify every class of blood pressure medication. However, official guidance does note that Solvazinc absorption can be reduced by certain supplements, particularly oral iron or calcium, and dose separation is typically required to minimize this effect.


Q: Does Solvazinc cause dizziness or drowsiness?

A: Lethargy, which is described as a state of deep drowsiness or lack of energy, is listed as a possible side effect of Solvazinc, though its frequency is not known. Severe lethargy has also been reported in rare cases associated with acute zinc overdose.


Q: Is Solvazinc used to treat general fatigue?

A: The official use for Solvazinc is the correction of a confirmed zinc deficiency, which is its therapeutic purpose. While zinc is essential for enzymes involved in energy metabolism, it is not formally indicated as a treatment for general fatigue.


Q: What are the signs of an allergic reaction to Solvazinc?

A: Hypersensitivity, or a severe allergic reaction, is a contraindication for using Solvazinc. Regulatory sources indicate that in the event of signs of an allergic reaction being observed, emergency medical assistance should be sought. These signs typically include hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.


Q: Does Solvazinc affect sleep patterns?

A: Research has been conducted to explore the relationship between the drug and sleep quality metrics, specifically in addition to studies focusing on pain relief. Other non-regulatory studies have investigated the potential combination of zinc with melatonin.


Q: Are there any common interactions with antacids and Solvazinc?

A: Official documents note that the absorption of zinc can be reduced by oral preparations containing calcium or iron. Since many common antacid products contain one or both of these minerals, separating the administration time is generally required to minimize this interaction.


Q: What research is currently being done on new uses for Solvazinc?

A: Beyond its main use for zinc deficiency, research has been conducted to investigate Solvazinc's effect on sleep quality metrics. Studies have also explored its use in patients with certain types of chronic neuropathic pain who had not previously responded to two prior treatments.


Q: What is the shelf life of Solvazinc?

A: The regulatory labeling emphasizes that Solvazinc must not be used after the expiry date printed on the carton or packaging. The medicine must also be stored under specific conditions, which include keeping it below 25 C and ensuring it is protected from moisture.


Q: Is Solvazinc generally well-tolerated?

A: The safety profile indicates that the most commonly reported side effects are associated with the gastrointestinal system. These include vomiting (which is a very common side effect, especially in children) and other effects like nausea and abdominal pain.


Q: Can I take Solvazinc if I am taking multivitamins?

A: Official information states that the body's absorption of zinc may be reduced by supplements that contain oral iron or calcium. Because these minerals are common components of multivitamins, separating the administration time is typically required to minimize the potential for this type of interaction.


Q: Is Solvazinc appropriate for older adults?

A: Official guidance states that when Solvazinc is used in older (geriatric) adults, the dose selection should be individualized. This means that the dose is determined based on the individual's specific nutritional requirements and overall clinical condition.


Q: Can Solvazinc interfere with birth control pills?

A: Regulatory drug interaction checkers do not generally indicate that zinc interferes with the effectiveness of hormonal contraceptives (birth control pills). However, some official sources have noted that certain oral contraceptives have been associated with lower zinc levels in the body.


Q: Why do official guidelines mention monitoring blood levels when taking Solvazinc?

A: The monitoring of a patient's zinc status is routinely recommended in clinical guidelines, particularly for those on long-term treatment. This monitoring is directly related to the recognized risk of developing a copper deficiency, which can occur with prolonged high-dose use of zinc.


Q: What if I take too much Solvazinc by mistake?

A: According to regulatory sources, symptoms associated with ingesting high doses of zinc can include nausea, vomiting, diarrhea, fever, metallic taste, and lethargy. Treatment for an overdose typically involves providing supportive medical care.


Q: Can Solvazinc be taken with thyroid medication?

A: While there is no known major drug-to-drug interaction between Solvazinc and common thyroid medications (like levothyroxine), experts note that it is typically necessary to separate the administration times by at least four hours. This is done to minimize the risk that the zinc will reduce the body's absorption of the thyroid medicine.


Q: Why do some people experience a metallic taste when taking Solvazinc?

A: A metallic taste is a symptom noted by regulatory sources that has been observed in rare cases. This specific symptom has been associated with acute zinc poisoning that can occur following the ingestion of very high doses.

How should Solvazinc be stored and disposed of?

How to Store and Dispose of Solvazinc?

The official storage and disposal requirements for Solvazinc Effervescent Tablets are governed by regulatory labeling to ensure product integrity and public safety.

Storage Conditions and Protection

The medicine must be stored at a temperature below 25 C and kept in the original packaging to protect it from moisture. It is required to keep the product out of the sight and reach of children at all times. Do not use Solvazinc after the expiry date printed on the carton.

Official Disposal Instructions

To help protect the environment, unused or expired Solvazinc must not be thrown away via wastewater or household waste. The official procedure requires consulting a pharmacist for instructions on how to properly discard the medicine according to local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Solvazinc found in:

A-Z Index: